On 8th February 2017 two votes took place in the Lords on amendments to the Government’s Health Services Medical Supplies (Costs) Bill. The Bishops of Chester and St Albans took part in the first vote and the Bishops of Carlisle, Chester and St Albans in the second.
Lord Warner moved amendment 3, before clause 1, to insert the new clause “Duty to have regard to the life sciences sector and access to new medicines and treatments.” This sought to ensure that in the enactment of the new provisions of the Bill, the Government must have regard to promoting a growing life sciences sector, and ensure that patients have rapid clinical access to new clinically effective and cost-effective medicines and treatments approved by the National Institute for Health and Care Excellence through their technology appraisal process. The House divided:
Lord Hunt of Kings Heath moved amendment 12, as an amendment to amendment 11, in clause 6, in subsection (5), before “manufacturing” insert “access to”. This sought to amend the following Government amendment:
11: Clause 6, page 5, leave out lines 46 to 48 and insert—
“(5) Regulations under this section must require the Secretary of State to give a UK producer an information notice if information is required in respect of the costs incurred by the producer in connection with the manufacturing, distribution or supply of UK health service products (other than costs which relate to any transaction with a UK producer for those products).
The House divided: